Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7919.016
uM
inf
inf
0.6576 0.6576 0.0000 0.0567
0.5253
3.5497
SUM159PT
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7920.016
uM
inf
147.84710
0.8503 0.7670 4.7960 -0.0230
0.6294
4.3230
SUM159PT
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
9042.016
uM
inf
2.5420
0.8028 0.7523 4.9987 0.0695
0.7154
2.8524
SUM159PT
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7918.016
uM
75.36610
111.09270
-0.5212 -1.0000 2.8314 0.1653
0.9046
3.1190
SUM159PT
TNBC
Basal B
17-AAG
HSP90
HSP90
7919.04
uM
0.04167
0.05119
-0.4725 -0.2657 2.0719 0.7284
0.9791
3.7375
SUM159PT
TNBC
Basal B
17-AAG
HSP90
HSP90
9042.05
uM
0.01234
0.0160
-0.2937 -0.2124 1.3656 0.8203
0.9834
3.1161
SUM159PT
TNBC
Basal B
17-AAG
HSP90
HSP90
7920.05
uM
0.06950
0.07046
-0.1466 -0.0220 3.1217 0.5658
0.9871
4.1624
SUM159PT
TNBC
Basal B
17-AAG
HSP90
HSP90
7918.037
uM
0.04235
0.04699
-0.2412 -0.1989 3.2195 0.7156
0.9877
2.8917
SUM159PT
TNBC
Basal B
5-DFUR
TYMS
TYMS
11057.143
uM
117.49380
138.80550
0.0197 -0.0551 0.6266 0.3060
0.9924
4.1426
SUM159PT
TNBC
Basal B
5-FU
TYMS
TYMS
7918.017
uM
55.49690
51.00660
-0.0611 0.0231 0.5595 0.4429
0.9278
3.1833
SUM159PT
TNBC
Basal B
5-FU
TYMS
TYMS
7919.017
uM
68.19810
71.10910
-0.0335 -0.0155 0.7291 0.4298
0.9904
3.7958
SUM159PT
TNBC
Basal B
5-FU
TYMS
TYMS
7920.13
uM
130.24210
83.00670
0.1415 0.1407 0.7336 0.3613
0.9971
4.3955
SUM159PT
TNBC
Basal B
Afatinib
EGFR/HER2
ErbB
11057.158
uM
3.9340
7.18480
-0.7343 -0.7885 1.5717 0.3293
0.9976
3.8594
SUM159PT
TNBC
Basal B
AG1024
IGF1R
RTK
7531.066
uM
inf
inf
1.0194 1.0194 0.0000 -0.0256
-1.3735
3.3129
SUM159PT
TNBC
Basal B
AG1478
EGFR
ErbB
7918.016
uM
inf
inf
0.6825 0.6825 0.0000 0.1161
0.2905
3.1190
SUM159PT
TNBC
Basal B
AG1478
EGFR
ErbB
9042.016
uM
12.53920
8.6790
0.2330 0.4206 5.0000 0.1638
0.8252
2.8524
SUM159PT
TNBC
Basal B
AG1478
EGFR
ErbB
7919.016
uM
32.55880
79.83270
-0.4465 -1.0000 1.2249 0.1931
0.9895
3.5497
SUM159PT
TNBC
Basal B
AG1478
EGFR
ErbB
7920.016
uM
25.90870
33.39040
-0.2225 -0.2898 1.8023 0.1605
0.9971
4.3230
SUM159PT
TNBC
Basal B
AS-252424
PI3K
PI3K
11057.158
uM
inf
3.06690
0.4735 0.5788 5.0000 0.0928
0.9104
3.8594
SUM159PT
TNBC
Basal B
AS-252424
PI3K
PI3K
10520.141
uM
10.8170
5.94660
0.3744 0.3678 2.2237 0.1320
0.950
3.6374
SUM159PT
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7531.073
uM
234.36780
162.60140
0.6820 0.3991 4.3786 -0.0035
0.9044
3.4904
SUM159PT
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
11057.072
uM
240.88130
167.67830
0.6604 0.3171 2.7765 0.0050
0.9563
4.0230
SUM159PT
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
10520.072
uM
49.21310
59.38050
-0.5968 -0.6159 4.2745 0.0997
0.9925
3.3637
SUM159PT
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
14921.203
uM
0.00175
0.00299
-0.7142 -0.7255 1.6650 1.3482
0.9972
3.0799
SUM159PT
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
14921.203
uM
0.00175
0.00299
-0.7142 -0.7255 1.6650 1.3482
0.9972
3.0799